Protective effects of baicalein and wogonin against benzo[a]pyrene- and aflatoxin B1-induced genotoxicities11Abbreviations: AF, aflatoxin; AFB1, aflatoxin B1; AHH, benzo[a]pyrene hydroxylation; CYP, cytochrome P450; and AFO, aflatoxin B1 oxidation.
Authors:
- 1 December 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 62 (12) , 1653-1660
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- In vitro and in vivo effects of naringin on cytochrome P450-dependent monooxygenase in mouse liverLife Sciences, 1999
- Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sitesCarcinogenesis, 1999
- Flavonoids: Old and new aspects of a class of natural therapeutic drugsLife Sciences, 1999
- Oxidation of Aflatoxin B1 by Bacterial Recombinant Human Cytochrome P450 EnzymesChemical Research in Toxicology, 1995
- Oxidation of Benzo[a]pyrene by Recombinant Human Cytochrome P450 EnzymesChemical Research in Toxicology, 1995
- Mechanisms of Aflatoxin CarcinogenesisAnnual Review of Pharmacology and Toxicology, 1994
- Studies on the Metabolism of Benzo[a]Pyrene and Dose-Dependent Differences in the Mutagenic Profile of Its Ultimate Carcinogenic MetaboliteDrug Metabolism Reviews, 1994
- Risk assessment for benzo[a]pyreneRegulatory Toxicology and Pharmacology, 1991
- In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoidsCarcinogenesis, 1990
- Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: Linear correlation with hepatic cancer riskRegulatory Toxicology and Pharmacology, 1989